{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:22:35Z","timestamp":1648898555894},"reference-count":28,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MaSeb"],"published-print":{"date-parts":[[2010,4,1]]},"abstract":"<jats:title>Absztrakt<\/jats:title>\n        <jats:p>\n          <jats:italic>Bevezet\u00e9s:<\/jats:italic> Transzplant\u00e1ci\u00f3t k\u00f6vet\u0151en kialakul\u00f3 leggyakoribb tumorok a non-melanoma b\u0151rtumorok (Non-Melanoma Skin Cancer, NMSC). Klinikai kollabor\u00e1ci\u00f3 keretein bel\u00fcl \u2013 Magyarorsz\u00e1gon els\u0151k\u00e9nt \u2013 bevezett\u00fck a transzplant\u00e1lt betegek rendszeres b\u0151rgy\u00f3gy\u00e1szati sz\u0171r\u0151vizsg\u00e1lat\u00e1t, valamint vizsg\u00e1ltuk kialakul\u00e1suk gyakoris\u00e1g\u00e1t \u00e9s kiv\u00e1lt\u00f3 t\u00e9nyez\u0151it. <jats:italic>Betegek \u00e9s m\u00f3dszerek:<\/jats:italic> A p\u00e9csi Seb\u00e9szeti Klinika gondoz\u00e1s\u00e1ban \u00e1ll\u00f3 vese- \u00e9s hasny\u00e1lmirigy-vese transzplant\u00e1ci\u00f3n \u00e1tesett betegek k\u00f6z\u00fcl 2008 szeptember\u00e9t\u0151l 116 beteget (70 f\u00e9rfi, 46 n\u0151) vontunk be. Ez a beteg teljes testfel\u00fclet\u00e9nek b\u0151rgy\u00f3gy\u00e1szati vizsg\u00e1lat\u00e1b\u00f3l \u00e9s a rizik\u00f3faktorokat felm\u00e9r\u0151 k\u00e9rd\u0151\u00edv kit\u00f6lt\u00e9s\u00e9b\u0151l \u00e1llt. <jats:italic>Eredm\u00e9nyek:<\/jats:italic> A sz\u0171r\u0151vizsg\u00e1lat sor\u00e1n 11 betegn\u00e9l 16 NMSC-t tal\u00e1ltunk (13,8%, \u00e1tlag\u00e9letkor: 49,3 \u00e9v, f\u00e9rfi : n\u0151 = 1 : 1), melyek kialakul\u00e1s\u00e1nak \u00e1tlagideje a transzplant\u00e1ci\u00f3t k\u00f6vet\u0151en 4,1 \u00e9v volt. A sz\u00f6vettani vizsg\u00e1lat 13 basocellularis carcinom\u00e1t (BCC) \u00e9s 3 squamocellularis carcinom\u00e1t (SCC) igazolt. A tumorok BCC : SCC ar\u00e1nya 4 : 1 volt. A NMSC-ok el\u0151fordul\u00e1sa szignifik\u00e1nsan magasabb volt azokn\u00e1l a betegekn\u00e9l, akik cyclosporint szedtek, valamint akiknek \u00e9let\u00fck sor\u00e1n 2-n\u00e9l t\u00f6bb nap\u00e9g\u00e9s\u00fck volt, vagy tart\u00f3san k\u00fclt\u00e9ri munk\u00e1t v\u00e9geztek (<jats:italic>p<\/jats:italic> &lt; 0,05). <jats:italic>K\u00f6vetkeztet\u00e9sek:<\/jats:italic> Eddigi adataink igazolj\u00e1k a transzplant\u00e1lt betegek rendszeres b\u0151rgy\u00f3gy\u00e1szati sz\u0171r\u00e9s\u00e9nek jelent\u0151s\u00e9g\u00e9t, valamint a szorosabb egy\u00fcttm\u0171k\u00f6d\u00e9s fontoss\u00e1g\u00e1t a transzplant\u00e1ci\u00f3s seb\u00e9szek \u00e9s b\u0151rgy\u00f3gy\u00e1szok k\u00f6z\u00f6tt. Eredm\u00e9nyeink a nemzetk\u00f6zi adatoknak megfelelnek, kiv\u00e9ve a BCC : SCC ar\u00e1nyt. Ennek a k\u00fcl\u00f6nbs\u00e9gnek a tiszt\u00e1z\u00e1s\u00e1hoz tov\u00e1bbi vizsg\u00e1latokat tervez\u00fcnk.<\/jats:p>","DOI":"10.1556\/maseb.63.2010.2.6","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T01:02:08Z","timestamp":1272330128000},"page":"84-90","source":"Crossref","is-referenced-by-count":0,"title":["A szervtranszplant\u00e1ci\u00f3t k\u00f6vet\u0151 non-melanoma b\u0151rtumorok klinikai vizsg\u00e1lata"],"prefix":"10.1556","volume":"63","author":[{"given":"Tam\u00e1s","family":"Fekecs","sequence":"first","affiliation":[{"name":"1 B\u0151r-, Nemik\u00f3rtani \u00e9s Onkodermatol\u00f3giai Klinika, P\u00e9csi Tudom\u00e1nyegyetem, Klinikai K\u00f6zpont, 7624, P\u00e9cs, Kod\u00e1ly Zolt\u00e1n \u00fat 20."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"K\u00e1d\u00e1r","sequence":"additional","affiliation":[{"name":"1 B\u0151r-, Nemik\u00f3rtani \u00e9s Onkodermatol\u00f3giai Klinika, P\u00e9csi Tudom\u00e1nyegyetem, Klinikai K\u00f6zpont, 7624, P\u00e9cs, Kod\u00e1ly Zolt\u00e1n \u00fat 20."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zita","family":"Batty\u00e1ni","sequence":"additional","affiliation":[{"name":"1 B\u0151r-, Nemik\u00f3rtani \u00e9s Onkodermatol\u00f3giai Klinika, P\u00e9csi Tudom\u00e1nyegyetem, Klinikai K\u00f6zpont, 7624, P\u00e9cs, Kod\u00e1ly Zolt\u00e1n \u00fat 20."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1roly","family":"Kalm\u00e1r-Nagy","sequence":"additional","affiliation":[{"name":"2 Seb\u00e9szeti Klinika, P\u00e9csi Tudom\u00e1nyegyetem, Klinikai K\u00f6zpont, P\u00e9cs"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Szak\u00e1ly","sequence":"additional","affiliation":[{"name":"2 Seb\u00e9szeti Klinika, P\u00e9csi Tudom\u00e1nyegyetem, Klinikai K\u00f6zpont, P\u00e9cs"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"W\u00e9ber","sequence":"additional","affiliation":[{"name":"3 Seb\u00e9szeti Oktat\u00f3 \u00e9s Kutat\u00f3 Int\u00e9zet, P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, P\u00e9cs"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6rs P\u00e9ter","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"2 Seb\u00e9szeti Klinika, P\u00e9csi Tudom\u00e1nyegyetem, Klinikai K\u00f6zpont, P\u00e9cs"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ferencz","sequence":"additional","affiliation":[{"name":"3 Seb\u00e9szeti Oktat\u00f3 \u00e9s Kutat\u00f3 Int\u00e9zet, P\u00e9csi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, P\u00e9cs"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/01.ASN.0000126194.77004.9B","article-title":"Malignancy in renal transplantation","volume":"15","author":"Morath C","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2","first-page":"109","article-title":"A b\u0151rseb\u00e9szet helye a b\u0151rgy\u00f3gy\u00e1szatban","volume":"3","author":"Juh\u00e1sz I","year":"2007","journal-title":"B\u0151rgy\u00f3gy\u00e1szati \u00e9s Venerol\u00f3giai Szemle"},{"key":"3","first-page":"2321","article-title":"A b\u0151r rosszindulat\u00fa daganatai","volume":"147","author":"Gilde K","year":"2006","journal-title":"Orv Hetil"},{"key":"4","first-page":"408","article-title":"Incidence and types of malignancies in renal transplant recipients in Iraq","volume":"17","author":"Altaee IK","year":"2006","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.2005.07094.x","article-title":"Melanomas in renal transplant recipients","volume":"154","author":"Mire L","year":"2006","journal-title":"Br J Dermatol"},{"key":"6","first-page":"703","article-title":"Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy","volume":"6","author":"Zamanian A","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"7","volume-title":"Fitzpatrick\u2019s color atlas and synopsis of clinical dermatology","author":"Wolff K","year":"2005"},{"key":"8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ndt\/13.6.1374","article-title":"Skin cancers in transplant patients","volume":"13","author":"Dr\u00e9no B","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/ndt\/gfg023","article-title":"Skin cancers after transplantation","volume":"18","author":"Dr\u00e9no B","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archderm.141.8.978","article-title":"Sunscreen use before and after transplantation and assessment of rist factors associated with skin cancer development in renal transplant recipients","volume":"141","author":"Moloney FJ","year":"2005","journal-title":"Arch Dermatol"},{"key":"11","first-page":"31","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipients. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"12","first-page":"2115","article-title":"A vese\u00e1t\u00fcltet\u00e9st k\u00f6vet\u0151en kialakul\u00f3 rosszindulat\u00fa daganatok","volume":"45","author":"Vegs\u0151 Gy","year":"2007","journal-title":"Orv Hetil"},{"key":"13","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.transproceed.2007.08.022","article-title":"De novo malignancies after renal transplantation \u2013 a single-center experience in the Balkans","volume":"39","author":"Popov Z","year":"2007","journal-title":"Transplant Proc"},{"key":"14","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.transproceed.2007.08.016","article-title":"Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy","volume":"39","author":"Abou Ayache R","year":"2007","journal-title":"Transplant Proc"},{"key":"15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/TP.0b013e318180482d","article-title":"Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience","volume":"86","author":"Comeau S","year":"2008","journal-title":"Transplantation"},{"key":"16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1432-2277.2009.00846.x","article-title":"Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience","volume":"22","author":"Ju MK","year":"2009","journal-title":"Transpl Int"},{"key":"17","first-page":"288","article-title":"Occurrence, types, and therapies of malignant tumors in recipients of renal transplantation","volume":"31","author":"Liu GH","year":"2009","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.urology.2007.02.046","article-title":"De novo malignancies after kidney transplantation","volume":"69","author":"Hung YM","year":"2007","journal-title":"Urology"},{"key":"19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.2009.09454.x","article-title":"Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure","volume":"161","author":"Terhorst D","year":"2009","journal-title":"Br J Dermatol"},{"key":"20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/S0190-9622(03)00902-2","article-title":"Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia","volume":"49","author":"Ramsay HM","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.transproceed.2009.03.032","article-title":"Malignancies in 2,753 kidney recipients transplanted during a 39-year experience","volume":"41","author":"Berardinelli L","year":"2009","journal-title":"Transplant Proc"},{"key":"22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-0-387-78574-5_6","article-title":"Post-transplant skin cancer: the influence of organ and pre-transplant disease","volume":"146","author":"Euvrard S","year":"2009","journal-title":"Cancer Treat Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/TP.0b013e3181a5ce2e","article-title":"Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients","volume":"87","author":"Urwin HR","year":"2009","journal-title":"Transplantation"},{"key":"24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e3181a07a57","article-title":"Minimizing the risk of posttransplant malignancy","volume":"87","author":"Campistol JM","year":"2009","journal-title":"Transplantation"},{"key":"25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MNH.0b013e3282f06bba","article-title":"Cancer after renal transplantation","volume":"16","author":"Vasudev B","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"26","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen JH","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1432-2277.2006.00330.x","article-title":"Post-transplant de novo malignancies in renal transplant recipients: the past and present","volume":"19","author":"Kauffman HM","year":"2006","journal-title":"Transpl Int"},{"key":"28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor AL","year":"2005","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Magyar Seb\u00e9szet"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/1046\/63\/2\/article-p84.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akademiai.com\/doi\/pdf\/10.1556\/maseb.63.2010.2.6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:59:06Z","timestamp":1590141546000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/maseb.63.2010.2.6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":28,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1556\/maseb.63.2010.2.6","relation":{},"ISSN":["0025-0295","1789-4301"],"issn-type":[{"value":"0025-0295","type":"print"},{"value":"1789-4301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,1]]}}}